Form 8-K - Current report:
SEC Accession No. 0001493152-21-016224
Filing Date
2021-07-06
Accepted
2021-07-06 16:07:35
Documents
1
Period of Report
2021-07-01
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 45451
  Complete submission text file 0001493152-21-016224.txt   46764
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 211074134
SIC: 2834 Pharmaceutical Preparations